Abbott Laboratories Statement of changes in Director/PDMR Shareholding (2420A)

TIDMABT

RNS Number : 2420A

Abbott Laboratories

03 June 2016

Notification to RNS

   Company:         Abbott Laboratories 
   TIDM:              ABT 
   Headline:          Abbott Laboratories Files Forms 4

Abbott Laboratories (the "Company")

3 June 2016

Abbott Laboratories Files Forms 4

The Company informs its shareholders that on 3 June, 2016, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, several Forms 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") were filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 4 can be found on the SEC website at http://www.sec.gov.

A copy of the Forms 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.

Issued by: Abbott Laboratories

CONTACT: Financial: Scott Leinenweber, +1-224-668-0791, Michael Comilla, +1-224-668-1872, or Jeffrey Byrne, +1-224-668-8808, or Media: Scott Stoffel, +1-224-668-5201, Darcy Ross, +1-224-667-3655, or Elissa Maurer, +1-224-668-3309.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAFKDELKKEAF

(END) Dow Jones Newswires

June 06, 2016 02:00 ET (06:00 GMT)

Abbott Labs (LSE:ABT)
過去株価チャート
から 11 2024 まで 12 2024